Epidemiology and virulence insights from MRSA and MSSA genome analysis

Future Microbiology

Volumn 6, Issue 5, 2011, Pages 513-532

  Lazarevic, Vladimir ^a   Beaume, Marie ^a   Corvaglia, Anna ^b   Hernandez, David ^a   Schrenzel, Jacques ^a   François, Patrice ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

genome; genotyping; MRSA; MSSA; sequencing

Indexed keywords

ADHESIN; BACTERIAL TOXIN; TRANSCRIPTOME;

BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; GENOME ANALYSIS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REVIEW;

ANTI-BACTERIAL AGENTS; GENOME, BACTERIAL; GENOTYPE; HUMANS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 79956149165     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.38     Document Type: Review

References (200)

1. Pittet D, Wenzel RP: Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch. Intern. Med. 155(11), 1177-1184 (1995).
2. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271(20), 1598-1601 (1994).
3. Steinberg JP, Clark CC, Hackman BO: Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: Impact of intravascular devices and methicillin resistance. Clin. Infect. Dis. 23(2), 255-259 (1996). (Pubitemid 126782779)
4. Hiramatsu K, Aritaka N, Hanaki H et al.: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350(9092), 1670-1673 (1997). (Pubitemid 28036828)
5. Baba T, Takeuchi F, Kuroda M et al.: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359(9320), 1819-1827 (2002). (Pubitemid 34607058)
6. Boyce JM: Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: Microbiology, epidemiology, and preventive measures. Infect. Control Hosp. Epidemiol. 13(12), 725-737 (1992).
7. Koessler T, Francois P, Charbonnier Y et al.: Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44(3), 1040-1048 (2006).
8. Gillet Y, Issartel B, Vanhems P et al.: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308), 753-759 (2002). (Pubitemid 34215075)
9. Obed A, Schnitzbauer AA, Bein T, Lehn N, Linde HJ, Schlitt HJ: Fatal pneumonia caused by Panton-Valentine Leucocidine-positive methicillin-resistant Staphylococcus aureus (PVL-MRSA) transmitted from a healthy donor in living-donor liver transplantation. Transplantation 81(1), 121-124 (2006). (Pubitemid 43122159)
10. Vandenesch F, Naimi T, Enright MC et al.: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg. Infect. Dis. 9(8), 978-984 (2003). (Pubitemid 36944519)
11. Liassine N, Auckenthaler R, Descombes MC, Bes M, Vandenesch F, Etienne J: Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J. Clin. Microbiol. 42(2), 825-828 (2004). (Pubitemid 38222671)
12. Jarraud S, Lyon GJ, Figueiredo AM et al.: Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 182(22), 6517-6522 (2000).
13. Sheagren JN: Staphylococcus aureus. The persistent pathogen (first of two parts). N. Engl. J. Med. 310(21), 1368-1373 (1984). (Pubitemid 14149090)
14. Sheagren JN: Staphylococcus aureus. The persistent pathogen (second of two parts). N. Engl. J. Med. 310(22), 1437-1442 (1984). (Pubitemid 14101300)
15. Novick RP: Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48(6), 1429-1449 (2003). (Pubitemid 36751052)
16. Archer GL: Staphylococcus aureus: A well-armed pathogen. Clin. Infect. Dis. 26(5), 1179-1181 (1998). (Pubitemid 28215485)
17. Lowy FD: Staphylococcus aureus infections. N. Engl. J. Med. 339(8), 520-532 (1998). n Review of Staphylococcus aureus virulence factors and epidemiology of S. aureus infections.
18. Vojtov N, Ross HF, Novick RP: Global repression of exotoxin synthesis by staphylococcal superantigens. Proc. Natl Acad. Sci. USA 99(15), 10102-10107 (2002). (Pubitemid 34831179)
19. De Boer ML, Kum WW, Pang LT, Chow AW: Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a d-galactosamine sensitized mouse model of lethal shock. Microb. Pathog. 27(2), 61-70 (1999). (Pubitemid 29397227)
20. De Boer ML, Kum WW, Chow AW: Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome. Can. J. Microbiol. 45(3), 250-256 (1999). (Pubitemid 29385791)
21. Kernodle DS, Voladri RK, Menzies BE, Hager CC, Edwards KM: Expression of an antisense hla fragment in Staphylococcus aureus reduces a-toxin production in vitro and attenuates lethal activity in a murine model. Infect. Immun. 65(1), 179-184 (1997). (Pubitemid 27008920)
22. Lew DP, Waldvogel FA: Osteomyelitis. Lancet 364(9431), 369-379 (2004).
23. Gittelman PD, Jacobs JB, Lebowitz AS, Tierno PM Jr: Staphylococcus aureus nasal carriage in patients with rhinosinusitis. Laryngoscope 101(7 Pt 1), 733-737 (1991).
24. Brook I, Finegold SM: Bacteriology of chronic otitis media. JAMA 241(5), 487-488 (1979). (Pubitemid 9228142)
25. Kauffman CA, Terpenning MS, He X et al.: Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. Am. J. Med. 94(4), 371-378 (1993). (Pubitemid 23106623)
26. Powers KA, Terpenning MS, Voice RA, Kauffman CA: Prosthetic joint infections in the elderly. Am. J. Med. 88(5N), N9-N13 (1990).
27. Kreiswirth B, Kornblum J, Arbeit RD et al.: Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 259(5092), 227-230 (1993). (Pubitemid 23041799)
28. Jorgensen JH: Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA. Eur. J. Clin. Microbiol. 5(6), 693-696 (1986). (Pubitemid 17213583)
29. Barrett FF, McGehee RF Jr, Finland M: Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N. Engl. J. Med. 279(9), 441-448 (1968).
30. Jones ME, Mayfield DC, Thornsberry C, Karlowsky JA, Sahm DF, Peterson D: Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicrob. Agents Chemother. 46(9), 3104-3105 (2002).
31. Campbell KM, Vaughn AF, Russell KL et al.: Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J. Clin. Microbiol. 42(9), 4050-4053 (2004). (Pubitemid 39296122)
32. Kazakova SV, Hageman JC, Matava M et al.: A clone of methicillin- resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352(5), 468-475 (2005). (Pubitemid 40175973)
33. Moran GJ, Krishnadasan A, Gorwitz RJ et al.: Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355(7), 666-674 (2006).
34. Hiramatsu K, Okuma K, Ma XX, Yamamoto M, Hori S, Kapi M: New trends in Staphylococcus aureus infections: Glycopeptide resistance in hospital and methicillin resistance in the community. Curr. Opin. Infect. Dis. 15(4), 407-413 (2002). (Pubitemid 34816430)
35. Chambers HF: The changing epidemiology of Staphylococcus aureus ? Emerg. Infect. Dis. 7(2), 178-182 (2001). (Pubitemid 32374323)
36. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F: Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): Population dynamics of an expanding community reservoir of MRSA. J. Infect. Dis. 190(10), 1730-1738 (2004). (Pubitemid 39487815)
37. Pan ES, Diep BA, Charlebois ED et al.: Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus - and their relation to community-associated disease activity. J. Infect. Dis. 192(5), 811-818 (2005). (Pubitemid 41193078)
38. Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M: Methicillin-resistant Staphylococcus aureus in pig farming. Emerg. Infect. Dis. 11(12), 1965-1966 (2005). (Pubitemid 43356102)
39. Moodley A, Stegger M, Bagcigil AF et al.: Spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. J. Antimicrob. Chemother. 58(6), 1118-1123 (2006). (Pubitemid 44884128)
40. Le Maréchal C, Hernandez D, Schrenzel J et al.: Genome sequence of two Staphylococcus aureus ovine strains that induce severe (strain O11) and mild (strain O46) mastitis. J. Bacteriol. 193(9), 2353-2354 (2011).
41. Kozytska S, Stauss D, Pawlik MC et al.: Identification of specific genes in Staphylococcus aureus strains associated with bovine mastitis. Vet. Microbiol. 145(3-4), 360-365 (2010).
42. Bronner S, Monteil H, Prevost G: Regulation of virulence determinants in Staphylococcus aureus: Complexity and applications. FEMS Microbiol. Rev. 28(2), 183-200 (2004). (Pubitemid 38510501)
43. O'Callaghan RJ, Callegan MC, Moreau JM et al.: Specific roles of a-toxin and b-toxin during Staphylococcus aureus corneal infection. Infect. Immun. 65(5), 1571-1578 (1997). (Pubitemid 27193571)
44. Haslinger B, Strangfeld K, Peters G, Schulze-Osthoff K, Sinha B: Staphylococcus aureus a-toxin induces apoptosis in peripheral blood mononuclear cells: Role of endogenous tumour necrosis factor-a and the mitochondrial death pathway. Cell Microbiol. 5(10), 729-741 (2003). (Pubitemid 37185049)
45. Jonsson P, Lindberg M, Haraldsson I, Wadstrom T: Virulence of Staphylococcus aureus in a mouse mastitis model: Studies of a hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect. Immun. 49(3), 765-769 (1985). (Pubitemid 15021542)
46. Dufour P, Gillet Y, Bes M et al.: Community-acquired methicillin- resistant Staphylococcus aureus infections in France: Emergence of a single clone that produces Panton-Valentine leukocidin. Clin. Infect. Dis. 35(7), 819-824 (2002).
47. Prevost G, Cribier B, Couppie P et al.: Panton-Valentine leucocidin and g-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63(10), 4121-4129 (1995).
48. Lina G, Gillet Y, Vandenesch F, Jones ME, Floret D, Etienne J: Toxin involvement in staphylococcal scalded skin syndrome. Clin. Infect. Dis. 25(6), 1369-1373 (1997). (Pubitemid 28022673)
49. Musser JM, Schlievert PM, Chow AW et al.: A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl Acad. Sci. USA 87(1), 225-229 (1990).
50. Lucet JC, Herrmann M, Rohner P, Auckenthaler R, Waldvogel FA, Lew DP: Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 34(12), 2312-2317 (1990).
51. Llewelyn M, Cohen J: Superantigens: Microbial agents that corrupt immunity. Lancet Infect. Dis. 2(3), 156-162 (2002). (Pubitemid 34462450)
52. Rajkovic A, El Moualij B, Uyttendaele M et al.: Immunoquantitative real-time PCR for detection and quantification of Staphylococcus aureus enterotoxin B in foods. Appl. Environ. Microbiol. 72(10), 6593-6599 (2006). (Pubitemid 44582898)
53. Chiang YC, Liao WW, Fan CM, Pai WY, Chiou CS, Tsen HY: PCR detection of Staphylococcal enterotoxins (SEs) N, O, P, Q, R, U, and survey of SE types in Staphylococcus aureus isolates from food-poisoning cases in Taiwan. Int. J. Food Microbiol. 121(1), 66-73 (2008).
54. Supersac G, Piemont Y, Kubina M, Prevost G, Foster TJ: Assessment of the role of g-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb. Pathog. 24(4), 241-251 (1998). (Pubitemid 28180051)
55. Foster TJ, Hook M: Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6(12), 484-488 (1998). (Pubitemid 29002881)
56. Que YA, Haefliger JA, Piroth L et al.: Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J. Exp. Med. 201(10), 1627-1635 (2005). (Pubitemid 40721006)
57. Moreillon P, Entenza JM, Francioli P et al.: Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63(12), 4738-4743 (1995).
58. Switalski LM, Patti JM, Butcher W, Gristina AG, Speziale P, Hook M: A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol. Microbiol. 7(1), 99-107 (1993). (Pubitemid 23011100)
59. Sinha B, Francois PP, Nusse O et al.: Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin a5b1. Cell Microbiol. 1(2), 101-117 (1999). (Pubitemid 129667957)
60. Clément S, Vaudaux P, Francois P et al.: Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J. Infect. Dis. 192(6), 1023-1028 (2005). (Pubitemid 41266799)
61. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD: Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20(1), 95-102 (1995).
62. Vaudaux P, Francois P, Bisognano C et al.: Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70(10), 5428-5437 (2002).
63. Zivkovic A, Sharif O, Stich K et al.: TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo. J. Immunol. 186(3), 1608-1617 (2011).
64. Volz T, Nega M, Buschmann J et al.: Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J. 24(10), 4089-4102 (2010).
65. Waldron DE, Lindsay JA: Sau1: A novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J. Bacteriol. 188(15), 5578-5585 (2006). (Pubitemid 44157315)
66. de Azavedo JC, Foster TJ, Hartigan PJ et al.: Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model. Infect. Immun. 50(1), 304-309 (1985). (Pubitemid 15239225)
67. Nair D, Memmi G, Hernandez D et al.: Whole genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J. Bacteriol. 193(9), 2332-2335 (2011).
68. Sung JM, Lloyd DH, Lindsay JA: Staphylococcus aureus host specificity: Comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology 154(Pt 7), 1949-1959 (2008).
69. Xu SY, Corvaglia AR, Chan SH, Zheng Y, Linder P: A type-IV modification-dependent restriction enzyme SauUSI from Staphylococcus aureus subsp. aureus USA300. Nucleic Acids Res. DOI: 10.1093/nar/gkr098 (2011) (Epub ahead of print).
70. Corvaglia AR, Francois P, Hernandez D, Perron K, Linder P, Schrenzel J: A novel restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains. Proc. Natl Acad. Sci. USA 107(26), 11954-11958 (2010). n Provides insights into horizontal gene transfer in S. aureus.
71. Kirby W: Extraction of a highly potent penicillin inactivator from penicillin resistant Staphylococci. Science 99(2579), 452-453 (1944).
72. Barber M: Methicillin-resistant staphylococci. J. Clin. Pathol. 14, 385-393 (1961).
73. Hryniewicz W: Epidemiology of MRSA. Infection 27(Suppl. 2), S13-S16 (1999). (Pubitemid 29440612)
74. Boyce JM, White RL, Spruill EY: Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections. J. Infect. Dis. 148(4), 763 (1983). (Pubitemid 13021684)
75. Pujol M, Pena C, Pallares R et al.: Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am. J. Med. 100(5), 509-516 (1996). (Pubitemid 26170474)
76. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D: Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 46(1), 43-49 (2000).
77. Abramson MA, Sexton DJ: Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs? Infect. Control Hosp. Epidemiol. 20(6), 408-411 (1999).
78. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C: Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit. JAMA 282(18), 1745-1751 (1999). (Pubitemid 29533605)
79. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE: Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost effective? Infect. Control Hosp. Epidemiol. 20(7), 473-477 (1999).
80. Nettleman MD, Trilla A, Fredrickson M, Pfaller M: Assigning responsibility: Using feedback to achieve sustained control of methicillin-resistant Staphylococcus aureus. Am. J. Med. 91(3B), S228-S232 (1991).
81. Cosseron-Zerbib M, Roque Afonso AM, Naas T et al.: A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: Evaluation and impact on infections caused by other micro-organisms. J. Hosp. Infect. 40(3), 225-235 (1998). (Pubitemid 28502306)
82. Cohen SH, Morita MM, Bradford M: A seven-year experience with methicillin-resistant Staphylococcus aureus. Am. J. Med. 91(3B), S233-S237 (1991).
83. Herwaldt LA: Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am. J. Med. 106(5A), S11-S18 (1999).
84. Rubinovitch B, Pittet D: Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: What have we learned? J. Hosp. Infect. 47(1), 9-18 (2001).
85. Cox RA, Conquest C, Mallaghan C, Marples RR: A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J. Hosp. Infect. 29(2), 87-106 (1995).
86. Richardson JF, Reith S: Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J. Hosp. Infect. 25(1), 45-52 (1993). (Pubitemid 23301507)
87. Aucken HM, Ganner M, Murchan S, Cookson BD, Johnson AP: A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J. Antimicrob. Chemother. 50(2), 171-175 (2002). (Pubitemid 34918845)
88. Tsiodras S, Gold HS, Sakoulas G et al.: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358(9277), 207-208 (2001). (Pubitemid 32718546)
89. Kloos WE, Bannerman TL: Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7(1), 117-140 (1994). (Pubitemid 24038092)
90. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K: Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: Genomic island SCC. Drug Resist. Updat. 6(1), 41-52 (2003). (Pubitemid 36396113)
91. Thomas L, van Hal S, O'Sullivan M, Kyme P, Iredell J: Failure of the BD GeneOhm StaphS/R assay for identification of Australian methicillin-resistant Staphylococcus aureus strains: Duplex assays as the "gold standard" in settings of unknown SCCmec epidemiology. J. Clin. Microbiol. 46(12), 4116-4117 (2008).
92. Ito T, Katayama Y, Asada K et al.: Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45(5), 1323-1336 (2001). (Pubitemid 32374098)
93. Berglund C, Ito T, Ikeda M, Ma XX, Soderquist B, Hiramatsu K: Novel type of staphylococcal cassette chromosome mec in a methicillin-resistant Staphylococcus aureus strain isolated in Sweden. Antimicrob. Agents Chemother. 52(10), 3512-3516 (2008).
94. Chongtrakool P, Ito T, Ma XX et al.: Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: A proposal for a new nomenclature for SCCmec elements. Antimicrob. Agents Chemother. 50(3), 1001-1012 (2006). (Pubitemid 43327806)
95. Heusser R, Ender M, Berger-Bachi B, McCallum N: Mosaic staphylococcal cassette chomosome mec (SCCmec) containing two recombinase loci and a new mec complex, B2. Antimicrob. Agents Chemother. 51(1), 390-393 (2007). (Pubitemid 46047739)
96. Berglund C, Molling P, Sjoberg L, Soderquist B: Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin. Microbiol. Infect. 11(6), 447-456 (2005). (Pubitemid 40744391)
97. Denis O, Deplano A, De Beenhouwer H et al.: Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J. Antimicrob. Chemother. 56(6), 1103-1106 (2005). (Pubitemid 43009827)
98. Naimi TS, LeDell KH, Como-Sabetti K et al.: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290(22), 2976-2984 (2003). (Pubitemid 37505530)
99. Gonzalez BE, Rueda AM, Shelburne SA III, Musher DM, Hamill RJ, Hulten KG: Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect. Control Hosp. Epidemiol. 27(10), 1051-1056 (2006). (Pubitemid 44670980)
100. Karas JA, Enoch DA, Emery MM: Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J. Hosp. Infect. 62(4), 480-486 (2006).
101. Tang YW, Procop GW, Persing DH: Molecular diagnostics of infectious diseases. Clin. Chem. 43(11), 2021-2038 (1997). (Pubitemid 27497800)
102. Van Belkum A, Van Leeuwen W, Kaufmann ME et al.: Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: A multicenter study. J. Clin. Microbiol. 36(6), 1653-1659 (1998). (Pubitemid 28226048)
103. Tang YW, Ellis NM, Hopkins MK, Smith DH, Dodge DE, Persing DH: Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J. Clin. Microbiol. 36(12), 3674-3679 (1998). (Pubitemid 28533250)
104. Tenover FC, Arbeit RD, Goering RV et al.: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J. Clin. Microbiol. 33(9), 2233-2239 (1995).
105. Enright MC, Spratt BG: Multilocus sequence typing. Trends Microbiol. 7(12), 482-487 (1999). (Pubitemid 30017699)
106. Frenay HM, Theelen JP, Schouls LM et al.: Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism. J. Clin. Microbiol. 32(3), 846-847 (1994). (Pubitemid 24062975)
107. Luijendijk A, Van Belkum A, Verbrugh H, Kluytmans J: Comparison of five tests for identification of Staphylococcus aureus from clinical samples. J. Clin. Microbiol. 34(9), 2267-2269 (1996). (Pubitemid 26272215)
108. Melles DC, Gorkink RF, Boelens HA et al.: Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J. Clin. Invest. 114(12), 1732-1740 (2004). (Pubitemid 40385529)
109. Sabat A, Krzyszton-Russjan J, Strzalka W et al.: New method for typing Staphylococcus aureus strains: Multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J. Clin. Microbiol. 41(4), 1801-1804 (2003). (Pubitemid 36428149)
110. Kuhn G, Francioli P, Blanc DS: Evidence for clonal evolution among highly polymorphic genes in methicillin-resistant Staphylococcus aureus. J. Bacteriol. 188(1), 169-178 (2006).
111. Clements MO, Foster SJ: Stress resistance in Staphylococcus aureus. Trends Microbiol. 7(11), 458-462 (1999). (Pubitemid 29528234)
112. Lindsay JA, Foster SJ: Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus. Mol. Gen. Genet. 262(2), 323-331 (1999). (Pubitemid 29440768)
113. Yang SJ, Dunman PM, Projan SJ, Bayles KW: Characterization of the Staphylococcus aureus CidR regulon: Elucidation of a novel role for acetoin metabolism in cell death and lysis. Mol. Microbiol. 60(2), 458-468 (2006).
114. Kuroda M, Ohta T, Uchiyama I et al.: Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357(9264), 1225-1240 (2001). n The first complete genome of S. aureus. (Pubitemid 32539050)
115. Baba T, Takeuchi F, Kuroda M et al.: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359(9320), 1819-1827 (2002). (Pubitemid 34607058)
116. Holden MT, Feil EJ, Lindsay JA et al.: Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc. Natl Acad. Sci. USA 101(26), 9786-9791 (2004). (Pubitemid 38869314)
117. Gill SR, Fouts DE, Archer GL et al.: Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187(7), 2426-2438 (2005). (Pubitemid 40389140)
118. Cassat JE, Dunman PM, McAleese F, Murphy E, Projan SJ, Smeltzer MS: Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J. Bacteriol. 187(2), 576-592 (2005). (Pubitemid 40100560)
119. Saunders NA, Underwood A, Kearns AM, Hallas G: A virulence-associated gene microarray: A tool for investigation of the evolution and pathogenic potential of Staphylococcus aureus. Microbiology 150(Pt 11), 3763-3771 (2004). (Pubitemid 39545322)
120. Dunman PM, Nesin M: Passive immunization as prophylaxis: When and where will this work? Curr. Opin. Pharmacol. 3(5), 486-496 (2003). (Pubitemid 37221128)
121. van Leeuwen WB, Jay C, Snijders S et al.: Multilocus sequence typing of Staphylococcus aureus with DNA array technology. J. Clin. Microbiol. 41(7), 3323-3326 (2003). (Pubitemid 36842341)
122. Fraser CM, Eisen J, Fleischmann RD, Ketchum KA, Peterson S: Comparative genomics and understanding of microbial biology. Emerg. Infect. Dis. 6(5), 505-512 (2000).
123. Escobar-Paramo P, Faivre N, Buckling A, Gougat-Barbera C, Hochberg ME: Persistence of costly novel genes in the absence of positive selection. J. Evol. Biol. 22(3), 536-543 (2009).
124. Gomez-Valero L, Latorre A, Silva FJ: The evolutionary fate of nonfunctional DNA in the bacterial endosymbiont Buchnera aphidicola. Mol. Biol. Evol. 21(11), 2172-2181 (2004). (Pubitemid 39391994)
125. Harris SR, Feil EJ, Holden MT et al.: Evolution of MRSA during hospital transmission and intercontinental spread. Science 327(5964), 469-474 (2010).
126. Feil EJ, Cooper JE, Grundmann H et al.: How clonal is Staphylococcus aureus? J. Bacteriol. 185(11), 3307-3316 (2003). (Pubitemid 36617742)
127. Montesinos I, Salido E, Delgado T, Cuervo M, Sierra A: Epidemiologic genotyping of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms. J. Clin. Microbiol. 40(6), 2119-2125 (2002). (Pubitemid 34596395)
128. von Eiff C, Becker K, Machka K, Stammer H, Peters G: Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344(1), 11-16 (2001). (Pubitemid 32064839)
129. Sung JM, Lloyd DH, Lindsay JA: Staphylococcus aureus host specificity: Comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology 154(Pt 7), 1949-1959 (2008).
130. Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM: Evolutionary genomics of Staphylococcus aureus: Insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc. Natl Acad. Sci. USA 98(15), 8821-8826 (2001). n Provides insights into epidemiology and pathogenesis of the main S. aureus clonal groups. (Pubitemid 32678111)
131. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG: The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl Acad. Sci. USA 99(11), 7687-7692 (2002). nn Describes the S. aureus population structure. (Pubitemid 34568752)
132. Fitzgerald JR, Musser JM: Evolutionary genomics of pathogenic bacteria. Trends Microbiol. 9(11), 547-553 (2001). (Pubitemid 34121941)
133. Moore PC, Lindsay JA: Genetic variation among hospital isolates of methicillin-sensitive Staphylococcus aureus: Evidence for horizontal transfer of virulence genes. J. Clin. Microbiol. 39(8), 2760-2767 (2001). (Pubitemid 32743987)
134. Lindsay JA, Moore CE, Day NP et al.: Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J. Bacteriol. 188(2), 669-676 (2006). (Pubitemid 43100554)
135. Jaureguy F, Landraud L, Passet V et al.: Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 9, 560 (2008).
136. Lipsitch M: Microbiology. Bacterial population genetics and disease. Science 292(5514), 59-60 (2001). (Pubitemid 32289120)
137. McClure JA, Conly JM, Elsayed S, Zhang K: Multiplex PCR assay to facilitate identification of the recently described staphylococcal cassette chromosome mec type VIII. Mol. Cell. Probes 24(4), 229-232 (2010).
138. Katayama Y, Takeuchi F, Ito T et al.: Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 185(9), 2711-2722 (2003). (Pubitemid 36514582)
139. Hiramatsu K, Cui L, Kuroda M, Ito T: The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9(10), 486-493 (2001). (Pubitemid 32939356)
140. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K: Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother. 48(7), 2637-2651 (2004). (Pubitemid 38823437)
141. Naimi TS, LeDell KH, Como-Sabetti K et al.: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290(22), 2976-2984 (2003). (Pubitemid 37505530)
142. Francois P, Renzi G, Pittet D et al.: A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J. Clin. Microbiol. 42(7), 3309-3312 (2004). (Pubitemid 38938100)
143. Projan SJ, Novick RP: The molecular basis of pathogenicity. In:The staphylococci in human diseases. Crossley KB, Archer GL (Eds). Churchill Livingstone, NY, USA 55-81 (1997).
144. Ji G, Beavis R, Novick RP: Bacterial interference caused by autoinducing peptide variants. Science 276(5321), 2027-2030 (1997). (Pubitemid 27443604)
145. Jarraud S, Mougel C, Thioulouse J et al.: Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70(2), 631-641 (2002). (Pubitemid 34083822)
146. Francois P, Koessler T, Huyghe A et al.: Rapid Staphylococcus aureus agr type determination by a novel multiplex real-time qPCR assay. J. Clin. Microbiol. 44(5), 1892-1895 (2006). (Pubitemid 43726295)
147. von Eiff C, Friedrich AW, Peters G, Becker K: Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 49(3), 157-162 (2004). (Pubitemid 38891721)
148. Verdier I, Reverdy ME, Etienne J, Lina G, Bes M, Vandenesch F: Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II. Antimicrob. Agents Chemother. 48(3), 1024-1027 (2004). (Pubitemid 38280360)
149. Francois P, Huyghe A, Charbonnier Y et al.: Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J. Clin. Microbiol. 43(7), 3346-3355 (2005). (Pubitemid 40981347)
150. Hanssen AM, Fossum A, Mikalsen J, Halvorsen DS, Bukholm G, Sollid JU: Dissemination of community-acquired methicillin-resistant Staphylococcus aureus clones in northern Norway: Sequence types 8 and 80 predominate. J. Clin. Microbiol. 43(5), 2118-2124 (2005). (Pubitemid 40656215)
151. Francois P, Harbarth S, Huyghe A et al.: Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg. Infect. Dis. 14(2), 304-307 (2008). (Pubitemid 351213683)
152. Sax H, Posfay-Barbe K, Harbarth S et al.: Successful control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J. Hosp. Infect. 63(1), 93-100 (2006).
153. Melles DC, Schouls L, Francois P et al.: High-throughput typing of Staphylococcus aureus by amplified fragment length polymorphism (AFLP) or multi-locus variable number of tandem repeat analysis (MLVA) reveals consistent strain relatedness. Eur. J. Clin. Microbiol. Infect. Dis. 28(1), 39-45 (2008).
154. Mee-Marquet N, Francois P, Domelier AS et al.: Variable-number tandem repeat analysis and multilocus sequence typing data confirm the epidemiological changes observed with Staphylococcus aureus strains isolated from bloodstream infections. J. Clin. Microbiol. 47(9), 2863-2871 (2009).
155. Mégevand C, Gervaix A, Heininger U et al.: Molecular epidemiology of nasal colonization by methicillin-susceptible Staphylococcus aureus in Swiss children. Clin. Microbiol. Infect. 16(9), 1414-1420 (2010).
156. Shore A, Rossney AS, Keane CT, Enright MC, Coleman DC: Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland. Antimicrob. Agents Chemother. 49(5), 2070-2083 (2005). (Pubitemid 40631626)
157. Charbonnier Y, Gettler BM, Francois P et al.: A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus. BMC Genomics 6, 95 (2005).
158. Seidl K, Müller S, Francois P et al.: Effect of a glucose impulse on the CcpA regulon in Staphylococcus aureus. BMC Microbiol. 18(9), 95 (2009).
159. Pohl K, Francois P, Stenz L et al.: CodY in Staphylococcus aureus: A regulatory link between metabolism and virulence gene expression. J. Bacteriol. 191(9), 2953-2963 (2009).
160. Petaïnen M, François P, Hyyrylainen HL et al.: Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10, 429 (2009).
161. Fischer A, Yang SJ, Bayer AS et al.: Daptomycin-resistance mechanisms in clinically-derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach. Antimicrob. Agents Chemother. (2011) (In press).
162. Kuhn G, Koessler T, Melles DC et al.: Comparative genomics of epidemic versus sporadic Staphylococcus aureus strains does not reveal molecular markers for epidemicity. Infect. Genet. Evol. 10(1), 89-96 (2009).
163. El Garch F, Hallin M, De Mendonça R, Denis O, Lefort A, Struelens MJ: StaphVar-DNA microarray analysis of accessory genome elements of community-acquired methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 63(5), 877-885 (2009).
164. Anderson KL, Roberts C, Disz T et al.: Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J. Bacteriol. 188(19), 6739-6756 (2006). (Pubitemid 44497886)
165. Roberts C, Anderson KL, Murphy E et al.: Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives. J. Bacteriol. 188(7), 2593-2603 (2006).
166. Smith EE, Buckley DG, Wu Z et al.: Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl Acad. Sci. USA 103(22), 8487-8492 (2006). (Pubitemid 43838482)
167. Weigel LM, Clewell DB, Gill SR et al.: Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302(5650), 1569-1571 (2003). (Pubitemid 37475701)
168. Cui L, Ma X, Sato K et al.: Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41(1), 5-14 (2003). (Pubitemid 36098547)
169. Mwangi MM, Wu SW, Zhou Y et al.: Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl Acad. Sci. USA 104(22), 9451-9456 (2007). nn Study of S. aureus evolution under selection pressure. (Pubitemid 47185800)
170. Rolain JM, Francois P, Hernandez D et al.: Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biol. Direct. 4, 1 (2009).
171. Donati L, Quadri P, Reiner M: Reactivation of osteomyelitis caused by Staphylococcus aureus after 50 years. J. Am. Geriatr. Soc. 47(8), 1035-1037 (1999). n S. aureus persistence and adaptation capacities. (Pubitemid 29380503)
172. Rogozin IB, Makarova KS, Natale DA et al.: Congruent evolution of different classes of non-coding DNA in prokaryotic genomes. Nucleic Acids Res. 30(19), 4264-4271 (2002). (Pubitemid 35175194)
173. Hernandez D, Francois P, Farinelli L, Osteras M, Schrenzel J: De novo bacterial genome sequencing: Millions of very short reads assembled on a desktop computer. Genome Res. 18(5), 802-809 (2008). (Pubitemid 351645070)
174. Argaman L, Hershberg R, Vogel J et al.: Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr. Biol. 11(12), 941-950 (2001). (Pubitemid 32589185)
175. Vogel J, Sharma CM: How to find small non-coding RNAs in bacteria. Biol. Chem. 386(12), 1219-1238 (2005). (Pubitemid 41790806)
176. Romby P, Charpentier E: An overview of RNAs with regulatory functions in gram-positive bacteria. Cell Mol. Life Sci. 67(2), 217-237 (2010).
177. Toledo-Arana A, Repoila F, Cossart P: Small noncoding RNAs controlling pathogenesis. Curr. Opin. Microbiol. 10(2), 182-188 (2007). (Pubitemid 46590044)
178. Toledo-Arana A, Dussurget O, Nikitas G et al.: The Listeria transcriptional landscape from saprophytism to virulence. Nature 459(7249), 950-956 (2009).
179. Waters LS, Storz G: Regulatory RNAs in bacteria. Cell 136(4), 615-628 (2009). nn The reference review for bacterial small RNAs.
180. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S: Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12(10), 3967-3975 (1993). nn Paper about the main regulator of virulence factor expression in S. aureus. (Pubitemid 23282772)
181. Benito Y, Kolb FA, Romby P, Lina G, Etienne J, Vandenesch F: Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression. RNA 6(5), 668-679 (2000). (Pubitemid 30318462)
182. Pichon C, Felden B: Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains. Proc. Natl Acad. Sci. USA 102(40), 14249-14254 (2005). (Pubitemid 41429684)
183. Vandenesch F, Kornblum J, Novick RP: A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J. Bacteriol. 173(20), 6313-6320 (1991).
184. Geissmann T, Chevalier C, Cros MJ et al.: A search for small noncoding RNAs in Staphylococcus aureus reveals a conserved sequence motif for regulation. Nucleic Acids Res. 37(21), 7239-7257 (2009).
185. Marchais A, Naville M, Bohn C, Bouloc P, Gautheret D: Single-pass classification of all noncoding sequences in a bacterial genome using phylogenetic profiles. Genome Res. 19(6), 1084-1092 (2009).
186. Beaume M, Hernandez D, Farinelli L et al.: Cartography of methicillin-resistant S. aureus transcripts: Detection, orientation and temporal expression during growth phase and stress conditions. PLoS ONE 5(5), E10725 (2010).
187. Anderson KL, Roux CM, Olson MW et al.: Characterizing the effects of inorganic acid and alkaline shock on the Staphylococcus aureus transcriptome and messenger RNA turnover. FEMS Immunol. Med. Microbiol. 60(3), 208-250 (2010).
188. Abu-Qatouseh LF, Chinni SV, Seggewiss J et al.: Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J. Mol. Med. 88(6), 565-575 (2010).
189. Wilderman PJ, Sowa NA, FitzGerald DJ et al.: Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis. Proc. Natl Acad. Sci. USA 101(26), 9792-9797 (2004). (Pubitemid 38869315)
190. Majdalani N, Vanderpool CK, Gottesman S: Bacterial small RNA regulators. Crit. Rev. Biochem. Mol. Biol. 40(2), 93-113 (2005). (Pubitemid 40604978)
191. Mandin P, Repoila F, Vergassola M, Geissmann T, Cossart P: Identification of new noncoding RNAs in Listeria monocytogenes and prediction of mRNA targets. Nucleic Acids Res. 35(3), 962-974 (2007). (Pubitemid 46344721)
192. Chevalier C, Boisset S, Romilly C et al.: Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation. PLoS Pathog. 6(3), E1000809 (2010).
193. Chabelskaya S, Gaillot O, Felden B: A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathog. 6(6), E1000927 (2010).
194. Bohn E, Muller S, Lauber J et al.: Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica. Cell Microbiol. 6(2), 129-141 (2004). (Pubitemid 38111594)
195. Melles DC, van Leeuwen WB, Snijders SV et al.: Comparison of multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), and amplified fragment length polymorphism (AFLP) for genetic typing of Staphylococcus aureus. J. Microbiol. Methods 69(2), 371-375 (2007). (Pubitemid 46551297)
196. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG: Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38(3), 1008-1015 (2000). (Pubitemid 30140551)
197. Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, Kreiswirth BN: Spa typing method for discriminating among Staphylococcus aureus isolates: Implications for use of a single marker to detect genetic micro-and macrovariation. J. Clin. Microbiol. 42(2), 792-799 (2004). (Pubitemid 38222664)
198. Reinoso E, Bettera S, Frigerio C, DiRenzo M, Calzolari A, Bogni C. RAPD-PCR analysis of Staphylococcus aureus strains isolated from bovine and human hosts. Microbiol Res. 159(3), 245-255 (2004). (Pubitemid 39098732)
199. Li H, Ruan J, Durbin R: Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 18(11), 1851-1858 (2008).
200. Rutherford K, Parkhill J, Crook J et al.: Artemis: Sequence visualization and annotation. Bioinformatics 16(10), 944-945 (2000).